Cargando…
MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease
Left ventricular hypertrophy (LVH) is a primary feature of cardiovascular complications in patients with chronic kidney disease (CKD). miRNA-30 is an important posttranscriptional regulator of LVH, but it is unknown whether miRNA-30 participates in the process of CKD-induced LVH. In the present stud...
Autores principales: | Bao, Jingfu, Lu, Yinghui, She, Qinying, Dou, Weijuan, Tang, Rong, Xu, Xiaodong, Zhang, Mingchao, Zhu, Ling, Zhou, Qing, Li, Hui, Zhou, Guohua, Yang, Zhongzhou, Shi, Shaolin, Liu, Zhihong, Zheng, Chunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262338/ https://www.ncbi.nlm.nih.gov/pubmed/33848263 http://dx.doi.org/10.1172/jci.insight.138027 |
Ejemplares similares
-
MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes
por: Lang, Yue, et al.
Publicado: (2019) -
Correlation research between osteoporosis and left ventricular hypertrophy in older men
por: Huang, Chenshu, et al.
Publicado: (2016) -
Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007) -
Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013) -
The value of myocardial work in patients with left ventricular hypertrophy
por: Fan, Jiali, et al.
Publicado: (2023)